Clinical Trial Update: The Effect of Autologous Autovaccine in Patients With Allergy on House-dust-mite [Phase 1]

View source ↗

Summary

Phase 1 trial assessing an autologous autovaccine for house dust mite allergy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• House Dust Mite Allergy

Drugs mentioned

• Autologous Autovaccine

Snippet

Sponsor: Johann Wolfgang Goethe University Hospital | Conditions: Allergens, House Dust Mites | Phase 1 | Status: COMPLETED